Position in OGN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$5,507,422
+$5,256,513 QoQ
Shares Held
406,752
+871.0% QoQ
Ownership
0.155%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#75
of 626 holders
Holding Since
Dec 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Vestcor Inc holds $147,490,942 across 10 Drug Manufacturers - General names. OGN ranks #6 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
171,882 | $43,652,871 | |
| 2 | LLY |
ELI LILLY & Co
|
22,615 | $27,125,111 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
169,809 | $21,453,669 | |
| 4 | MRK |
Merck & Co., Inc.
|
147,382 | $18,938,587 | |
| 5 | ABBV |
AbbVie Inc.
|
71,946 | $18,104,491 | |
| 6 | OGN |
Organon & Co.
This page
|
406,752 | $5,507,422 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
80,237 | $4,623,255 | |
| 8 | AMGN |
Amgen Inc
|
12,724 | $4,607,614 |
All Filings in OGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,507,422 | 406,752 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $250,909 | 41,888 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $300,336 | 41,888 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $447,363 | 41,888 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $189,544 | 19,581 | Shares | Sole | 2025-08-08 | |
| 2024-12-31 | $321,078 | 21,520 | Shares | Sole | 2025-02-10 | |
| 2024-03-31 | $358,046 | 19,045 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $274,628 | 19,045 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $330,621 | 19,045 | Shares | Sole | 2023-11-14 | |
| 2021-12-31 | $425,447 | 13,972 | Shares | Sole | 2022-02-15 | |
| No filing history on record for this holder in this stock. | ||||||